期刊文献+

HIV/AIDS患者治疗前后CD4^+、CD8^+细胞水平检测结果分析 被引量:2

下载PDF
导出
摘要 目的了解HIV/AIDS患者高效逆转录抗病毒(HAART)治疗前后CD4+、CD8+细胞计数水平变化情况。方法利用流式细胞分析技术对随机选取在本院住院治疗的177例HIV/AIDS患者进行治疗前后CD4+、CD8+检测,观察其治疗前后CD4+、CD8+细胞计数水平的变化。结果经过6个月的HAART治疗后,在选取的177例HIV/AIDS患者中,CD4+、CD8+细胞计数均较抗病毒治疗前有上升的趋势,治疗前后细胞计数比较差异具有非常显著统计学意义(P<均0.01)。结论 HIV/AIDS患者在持续HAART治疗后,CD4+、CD8+细胞计数将会提升到一定的水平,其可更好地提高HIV/AIDS患者的免疫力,在延长患者生命中具有重要的现实意义。
出处 《海南医学》 CAS 2012年第13期93-94,共2页 Hainan Medical Journal
基金 2009年广西南宁市科学研究与技术开发计划项目(编号:200901014C)
  • 相关文献

参考文献8

  • 1罗小成,朱章萍,邓荣婧,颜淑妩,陈倩,周凌.HIV感染者和AIDS患者T淋巴细胞亚群的变化及其临床意义[J].实用预防医学,2010,17(7):1423-1424. 被引量:7
  • 2Porichis F, Kaufmarm DE. HIV-specific CD4 T cells and immune con- trol of viral replication [J]. Curt Opin HIV AIDS, 2011, 6: 174-180.
  • 3Freel SA, Saunders KO, Tomaras GD. CD8+ T-cell-mediated control of HIV-1 and SIV infection [J]. Immunol Res, 2011, 49: 135-146,.
  • 4van Bockel D J, Price DA, Munier ML, et al. Persistent survival of prevalent elonotypes within an immtmodominant HIV gag-specific CD8+ T cell response [J]. J Immunol, 2011, 186: 359-371.
  • 5普冬,王霖.用流式细胞仪研究HIV/AIDS患者HAART的治疗效果[J].实用医技杂志,2008,15(4):479-481. 被引量:5
  • 6Piconi S, Trabattoni D, Gori A, et al. Immune activation, apoptosis, and Treg activity are associated with persistently reduced CD4+ T-cell counts during antiretroviral therapy [J]. AIDS, 2010, 24: 1991-2000.
  • 7Heath SL, Sabbaj S, Bansal A, et al. Goepfert PA.CD8 T-cell prolif- erative capacity is compromised in primary HIV-1 infection [J]. J Acquir Immune Defic Syndr, 2011, 56: 213-214.
  • 8李剑军,刘伟,唐志荣,梁富雄,周崇兴,梁淑家,鲁鸿燕,李国装,王斌,王江伟.儿童HIV感染者及AIDS患者高效抗反转录病毒治疗前后T淋巴细胞及亚群的变化[J].中华预防医学杂志,2010,44(11):989-992. 被引量:6

二级参考文献14

  • 1时代强,章松平,陶小华.32例HIV/AIDS患者HAART治疗效果[J].中国艾滋病性病,2006,12(4):352-352. 被引量:5
  • 2孙蕾,李倩如,杨璇,杜英,张世玺,徐立然.HAART对人类免疫缺陷病毒感染者淋巴细胞亚群的影响[J].现代免疫学,2007,27(4):306-309. 被引量:5
  • 3Klatzrnann D. Selective tropism of lymphadenophathy associated virus (LAV) for helper- inducer T- lymphocytes[J]. Science, 1984, 225: 59 - 62.
  • 4Lang W. Patterns of lymphocyte changes with human immunodeficiency - virus infection: from seroconversion to the development of AIDS[J ]. J Acquit Immune Defic Syndr, 1989, 2 : 63 - 69.
  • 5Murphy EL,Collier AC,Kalish LA,et al.Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease.Ann Intern Med,2001,135:17-26.
  • 6van Sighem AI,van de Wiel MA,Ghani AC,et al.Mortality and progression to AIDS after starting highly active antiretroviral therapy.AIDS,2003,17:2227-2236.
  • 7Kanfmann GR,Bloch M,Finlayson R,et al.The extent of HIV-1-related immunodeficiency and age predict the long-term CD4 T lymphocyte response to potent antiretroviral therapy.AIDS,2002,16:359-367.
  • 8Tarwater PM,Margolick JB,Jin J,et al.Increase and plateau of CD4 T-cell counts in the 3 (1/2) years after initiation of potent antiretroviral therapy.J Acquir Immune Defic Syndr,2001,27:168-175.
  • 9Hunt PW,Decks SG,Rodriguez B,et al.Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy.AIDS,2003,17:1907-1915.
  • 10Franco JM,León-Leal JA,Leal M,et al.CD4+ and CD8+T lymphocyte regeneration after anti-retroviral therapy in HIV-1-infected children and adult patients.Clin Exp Immunol,2000,119:493-498.

共引文献15

同被引文献9

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部